Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IDRA

Idera Pharmaceuticals (IDRA)

Idera Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IDRA
DateTimeSourceHeadlineSymbolCompany
03/12/20206:07AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
03/05/20208:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
03/05/20207:00AMGlobeNewswire Inc.Idera Pharmaceuticals Completes Enrollment in ILLUMINATE-301, its Registrational Trial of Tilsotolimod in Combination with Ip...NASDAQ:IDRAIdera Pharmaceuticals Inc
02/26/20205:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
02/20/20204:08PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
01/27/20205:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
01/15/20207:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
01/14/20207:00AMGlobeNewswire Inc.Idera Pharmaceuticals Provides 2020 Update and OutlookNASDAQ:IDRAIdera Pharmaceuticals Inc
01/10/20208:17AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
01/10/20208:14AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
01/10/20208:12AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
01/10/20208:10AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
01/10/20208:07AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
01/06/20204:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
01/06/20204:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
12/23/20194:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
12/23/20199:15AMGlobeNewswire Inc.Idera Pharmaceuticals Announces Private Placement Up To $97.7 MillionNASDAQ:IDRAIdera Pharmaceuticals Inc
11/06/20194:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
11/06/20194:08PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
11/06/20194:01PMGlobeNewswire Inc.Idera Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2019 Financial ResultsNASDAQ:IDRAIdera Pharmaceuticals Inc
10/31/20195:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
10/21/20197:00AMGlobeNewswire Inc.Idera Pharmaceuticals Announces New U.S. Patent For Tilsotolimod Through September 2037NASDAQ:IDRAIdera Pharmaceuticals Inc
09/30/20197:30AMGlobeNewswire Inc.Idera Pharmaceuticals Announces Initiation of the ILLUMINATE-206 Trial Evaluating Tilsotolimod in Combination with Nivolumab ...NASDAQ:IDRAIdera Pharmaceuticals Inc
09/06/20195:16PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IDRAIdera Pharmaceuticals Inc
09/04/20197:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
09/04/20197:00AMGlobeNewswire Inc.Idera Pharmaceuticals Announces Immuno-Oncology Clinical Research Collaboration with AbbVieNASDAQ:IDRAIdera Pharmaceuticals Inc
08/30/201912:00PMGlobeNewswire Inc.Idera Pharmaceuticals to Present at the Baird 2019 Global Healthcare ConferenceNASDAQ:IDRAIdera Pharmaceuticals Inc
08/29/20194:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
08/08/20199:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
08/08/20199:00AMGlobeNewswire Inc.Idera Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2019 Financial ResultsNASDAQ:IDRAIdera Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:IDRA